OpenVSafe by OpenVAERS
Search V-safe

LPH-21724-66116

3 vaccinations 2 coded responses 3 check-ins 2 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
193 / PA
Registered
2021-01-27
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-23
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-13
    Dose 2 — Pfizer-BioNTech
  3. 2021-01-27
    Registered in v-safe
  4. 2021-01-27
    Survey response — day 14, dose 2
    MedDRA: Bradycardia, Chills, Fatigue, Myalgia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Myalgia, chills, extreme fatigue, bradycardia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-27
    Report sent to call center — day 14, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  6. 2021-06-08
  7. 2021-06-08
  8. 2021-06-08
    Call successful
    Participant prefers to complete VAERS report online
  9. 2021-07-14
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  10. 2022-01-24
    Dose 3 — Pfizer-BioNTech
  11. 2022-04-25
    Survey response — 3 months, dose 3
    MedDRA: Fatigue, Hypogeusia, Hyposmia, Myalgia, Skin burning sensation — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Skin burning, fatigue, muscle aches, diminished taste and smell
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-04-25
    Report sent to call center — 3 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  13. 2022-04-26

Vaccinations

DoseDateManufacturerCo-administered
12020-12-23Pfizer-BioNTech
22021-01-13Pfizer-BioNTech
32022-01-24Pfizer-BioNTech No

Call center

2 call center cases

1 successful · 1 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 2 — day 14, dose 2

2021-01-27

Symptoms: Myalgia, chills, extreme fatigue, bradycardia

Release 11 — 3 months, dose 3

2022-04-25

Symptoms: Skin burning, fatigue, muscle aches, diminished taste and smell

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBradycardia ✓ ✓ ✓
SDChills ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHypogeusia · · ✓
SDHyposmia · · ✓
SDMyalgia ✓ ✓ ✓
SDSkin burning sensation · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release